KLK3 and Familial prostate cancer: Of two trials that compared surgery with watchful waiting,3,4 only the Scandinavian Prostate Cancer Group-4 trial (SPCG-4), conducted in the pre-PSA (Prostate Specific Antigen) era, evaluated costs.